Insider Trading & Ownership - Robinson Chandler

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Robinson Chandler
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-02-11
Sale
2021-02-16
7:35 pm
Monopar TherapeuticsMNPRTactic Pharma LLC
Mazar Andrew Paul
Robinson Chandler
O'Halloran Thomas V.
Brown Michael J
10% Owner
125,000$14.64$1,830,6204,277,940
(Indirect
Direct)
View
2019-12-18
Purchase
2019-12-20
6:33 pm
Monopar TherapeuticsMNPRTactic Pharma LLC
Mazar Andrew Paul
Robinson Chandler
O'Halloran Thomas V.
Brown Michael J
10% Owner
125,000$8$1,000,0004,402,940
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-30
Tax Withholding
2024-10-02
7:45 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
1,918$6.74941,525
(Direct)
View
2024-09-30
Exercise
2024-10-02
7:45 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
4,895$0941,525
(Direct)
View
2024-06-30
Tax Withholding
2024-07-02
6:07 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
8,684$0.7314,717,198
(Direct)
View
2024-06-30
Exercise
2024-07-02
6:07 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
24,476$04,717,198
(Direct)
View
2024-05-28
Exercise
2024-05-30
6:10 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
84,000$0.0014,528,071
(Direct)
View
2024-05-28
Exercise
2024-05-30
6:10 pm
N/A
2026-04-03
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
84,000$04,528,071
(Direct)
View
2024-03-31
Tax Withholding
2024-04-02
8:33 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
7,172$0.6814,641,882
(Direct)
View
2024-03-31
Exercise
2024-04-02
8:33 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
24,474$04,641,882
(Direct)
View
2023-12-31
Tax Withholding
2024-01-03
7:36 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
10,796$0.34029,156,003
(Direct)
View
2023-12-31
Exercise
2024-01-03
7:36 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
31,198$09,156,003
(Direct)
View
2023-09-30
Tax Withholding
2023-10-03
7:37 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
7,172$0.61994,659,850
(Direct)
View
2023-09-30
Exercise
2023-10-03
7:37 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
24,474$04,659,850
(Direct)
View
2023-06-30
Tax Withholding
2023-07-03
6:45 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
10,269$0.8554,667,022
(Direct)
View
2023-06-30
Exercise
2023-07-03
6:45 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
35,039$04,667,022
(Direct)
View
2023-03-31
Tax Withholding
2023-04-04
5:17 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
4,286$1.394,677,291
(Direct)
View
2023-03-31
Exercise
2023-04-04
5:17 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
13,911$04,677,291
(Direct)
View
2023-02-01
Option Award
2023-02-03
6:49 pm
N/A
2033-02-01
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
390,851$0548,746
(Direct)
View
2022-12-31
Exercise
2023-01-03
3:59 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
20,635$08,790,505
(Direct)
View
2022-12-31
Tax Withholding
2023-01-03
3:59 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
7,141$2.378,790,505
(Direct)
View
2022-09-30
Tax Withholding
2022-10-03
7:55 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
4,077$1.524,519,706
(Direct)
View
2022-09-30
Exercise
2022-10-03
7:55 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
13,911$04,519,706
(Direct)
View
2022-06-30
Exercise
2022-07-01
4:07 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
23,882$04,523,783
(Direct)
View
2022-06-30
Tax Withholding
2022-07-01
4:07 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
6,999$2.2994,523,783
(Direct)
View
2022-03-31
Tax Withholding
2022-04-01
5:28 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
1,155$2.554,530,782
(Direct)
View
2022-03-31
Exercise
2022-04-01
5:28 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
3,941$04,530,782
(Direct)
View
2022-02-02
Option Award
2022-02-04
7:37 pm
N/A
2032-02-01
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
370,540$0431,282
(Direct)
View
2022-01-01
Exercise
2022-01-04
2:17 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
6,724$04,325,120
(Direct)
View
2022-01-01
Tax Withholding
2022-01-04
2:17 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
2,327$3.214,325,120
(Direct)
View
2021-12-31
Exercise
2022-01-04
2:07 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
3,941$04,354,571
(Direct)
View
2021-12-31
Tax Withholding
2022-01-04
2:07 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
1,364$3.214,354,571
(Direct)
View
2021-09-30
Exercise
2021-10-01
7:24 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
3,941$04,355,935
(Direct)
View
2021-09-30
Tax Withholding
2021-10-01
7:24 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
1,155$4.874,355,935
(Direct)
View
2021-06-30
Tax Withholding
2021-07-02
5:10 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
2,310$5.894,357,090
(Direct)
View
2021-06-30
Exercise
2021-07-02
5:10 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
7,883$04,357,090
(Direct)
View
2021-01-26
Option Award
2021-01-28
6:51 pm
N/A
2031-01-25
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
133,060$0153,231
(Direct)
View
2021-01-01
Tax Withholding
2021-01-05
5:40 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
2,327$6.124,441,511
(Direct)
View
2021-01-01
Exercise
2021-01-05
5:40 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
6,724$04,441,511
(Direct)
View
2020-01-31
Option Award
2020-02-20
8:58 pm
N/A
N/A
Monopar TherapeuticsMNPRRobinson Chandler
Chief Executive Officer
138,648$0138,648
(Direct)
View